Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors

Yan, H ; Guo, YH ; Zhang, P ; Zu, LY ; Dong, XY ; Chen, L ; Tian, JW ; Fan, Xiaolong LU ; Wang, NP and Wu, XB , et al. (2005) In Biochemical and Biophysical Research Communications 336(1). p.287-298
Abstract
Recombinant adeno-associated virus serotype 2 (rAAV2) vector has been widely employed for gene therapy. Recent progress suggests that the new serotypes of AAV showed a better performance than did AAV2 in normal tissues. Here, we evaluate the potential role of human vascular endothelial growth factor (VEGF) gene transfer using rAAV vector pseudotyped with serotype I capsid proteins (rAAV1) in the treatment of muscle ischemia. In ischemic skeletal muscles, the rAAV1-LacZ vector allowed higher level, broader distribution, and long-lasting gene expression compared with the rAAV2-LacZ vector. Muscle VEGF165 production following the rAAV1-VEGF165 vector injection was 5-10 times higher than that following the rAAV2-VEGF165 vector injection.... (More)
Recombinant adeno-associated virus serotype 2 (rAAV2) vector has been widely employed for gene therapy. Recent progress suggests that the new serotypes of AAV showed a better performance than did AAV2 in normal tissues. Here, we evaluate the potential role of human vascular endothelial growth factor (VEGF) gene transfer using rAAV vector pseudotyped with serotype I capsid proteins (rAAV1) in the treatment of muscle ischemia. In ischemic skeletal muscles, the rAAV1-LacZ vector allowed higher level, broader distribution, and long-lasting gene expression compared with the rAAV2-LacZ vector. Muscle VEGF165 production following the rAAV1-VEGF165 vector injection was 5-10 times higher than that following the rAAV2-VEGF165 vector injection. VEGF165 production mediated by the rAAV1-VEGF165 vector stimulated a large set of neovascularization with relatively mature vascular structures and enhanced muscle regeneration in the ischemic skeletal muscles. Thus, the rAAV1-NEGF165 vector mediated gene transfer may be a therapeutic approach to peripheral vascular diseases. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
endothelial growth factor, vascular, gene delivery, serotype 1, adeno-associated virus, muscle, ischemia
in
Biochemical and Biophysical Research Communications
volume
336
issue
1
pages
287 - 298
publisher
Elsevier
external identifiers
  • pmid:16129416
  • wos:000231941500042
  • scopus:24344431602
ISSN
1090-2104
DOI
10.1016/j.bbrc.2005.08.066
language
English
LU publication?
yes
id
6ee7e7d8-898d-4d53-897d-abfa008a71e0 (old id 223798)
date added to LUP
2016-04-01 15:26:52
date last changed
2022-01-28 05:21:42
@article{6ee7e7d8-898d-4d53-897d-abfa008a71e0,
  abstract     = {{Recombinant adeno-associated virus serotype 2 (rAAV2) vector has been widely employed for gene therapy. Recent progress suggests that the new serotypes of AAV showed a better performance than did AAV2 in normal tissues. Here, we evaluate the potential role of human vascular endothelial growth factor (VEGF) gene transfer using rAAV vector pseudotyped with serotype I capsid proteins (rAAV1) in the treatment of muscle ischemia. In ischemic skeletal muscles, the rAAV1-LacZ vector allowed higher level, broader distribution, and long-lasting gene expression compared with the rAAV2-LacZ vector. Muscle VEGF165 production following the rAAV1-VEGF165 vector injection was 5-10 times higher than that following the rAAV2-VEGF165 vector injection. VEGF165 production mediated by the rAAV1-VEGF165 vector stimulated a large set of neovascularization with relatively mature vascular structures and enhanced muscle regeneration in the ischemic skeletal muscles. Thus, the rAAV1-NEGF165 vector mediated gene transfer may be a therapeutic approach to peripheral vascular diseases.}},
  author       = {{Yan, H and Guo, YH and Zhang, P and Zu, LY and Dong, XY and Chen, L and Tian, JW and Fan, Xiaolong and Wang, NP and Wu, XB and Gao, W}},
  issn         = {{1090-2104}},
  keywords     = {{endothelial growth factor; vascular; gene delivery; serotype 1; adeno-associated virus; muscle; ischemia}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{287--298}},
  publisher    = {{Elsevier}},
  series       = {{Biochemical and Biophysical Research Communications}},
  title        = {{Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors}},
  url          = {{http://dx.doi.org/10.1016/j.bbrc.2005.08.066}},
  doi          = {{10.1016/j.bbrc.2005.08.066}},
  volume       = {{336}},
  year         = {{2005}},
}